Reducing the risk of surgical site infections: Did we really think SCIP was going to lead us to the promised land?

Surgical Infections

Volumn 12, Issue 3, 2011, Pages 169-177

  Edmiston Jr , Charles E ^a   Spencer, Maureen ^b   Lewis, Brian D ^a   Brown, Kellie R ^a   Rossi, Peter J ^a   Henen, Cindy R ^c   Smith, Heidi W ^c   Seabrook, Gary R ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Universal Health Services   (United States)

^c FROEDTERT MEMORIAL LUTHERAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; CEFAZOLIN; CEFOTAXIME; CEFTIZOXIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC SENSITIVITY; ANTISEPSIS; BODY MASS; CONFERENCE PAPER; ESCHERICHIA COLI; EVIDENCE BASED MEDICINE; GLYCEMIC CONTROL; HUMAN; INCISION; INFECTION RISK; KLEBSIELLA PNEUMONIAE; MORBIDITY; MORTALITY; NONHUMAN; POSTOPERATIVE INFECTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; SURGICAL INFECTION; SURGICAL SITE INFECTION; TOURNIQUET;

GUIDELINES AS TOPIC; HUMANS; INFECTION CONTROL; RISK FACTORS; SURGICAL WOUND INFECTION; UNITED STATES;

EID: 80052761017     PISSN: 10962964     EISSN: 15578674     Source Type: Journal    
DOI: 10.1089/sur.2011.036     Document Type: Conference Paper

References (78)

1. Kobayashi M, Mohri Y, Inoue Y, et al. Continuous follow-up of surgical site infections for 30 days after colorectal surgery. World J Surg 2008;32:1142-1146.
2. de Lissovoy G, Fraeman K, Hutchins V, et al. Surgical site infection: Incidence and impact on hospital and treatment costs. Infect Control Hosp Epidemiol 2009;37:387-397.
3. Jones RS, Brown C, Opelka F. Surgeon compensation: 'Pay for performance': The American College of Surgeons National Surgical Quality Improvement Program, the Surgical Care Improvement Program and other programs. Surgery 2005;138:829-836.
4. Hedrick TL, Heckman JA, Smith RL, et al. Efficacy of protocol implementation on incidence of wound infection in colorectal operations. J Am Coll Surg 2007;205:532-538.
5. Pastor C, Artinyan A, Varma MG, et al. An increase in compliance with the surgical care improvement project does not prevent surgical site infections in colorectal surgery. Dis Colon Rectum 2010;53:24-30.
6. Stulberg JJ, Delany CP, Neuhauser DV, et al. Adherence to surgical care improvement projects measures and the association with postoperative infection. JAMA 2010;303:2470-2485.
7. Hawn MT. Surgical care improvement: Should performance measures have performance measures? JAMA 2010;303: 2527-2528.
8. Zerr KJ, Furnary AP, Grunkemeier GL, et al. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 1997;63:356-361.
9. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359-1367.
10. Wiener RS, Weiner DC, Larson RJ. Benefits and risk of tight glycemic control in critically ill adults: A meta-analysis. JAMA 2008;300:933-944.
11. Chan RP, Galas FR, Hajjar AL, et al. Intensive perioperative glucose control does not improve outcome of patients submitted to open heart surgery: A randomized, controlled trial. Clinics (São Paulo) 2009;64:51-60.
12. Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009;360:1283-1290.
13. Blumetti J, Luu M, Sarosi G, et al. Surgical site infections after colorectal surgery: Do risk factors vary depending on the type of infection considered? Surgery 2007;142:704-711.
14. Indelicato D, Grobmyer SR, Newlin H. Association between operative closure type and acute infection, local recurrence, and disease surveillance in patients undergoing breast-conserving therapy for early-stage breast cancer. Surgery 2007;141:645-653.
15. Alves A, Panis Y, Bouhnik Y, et al. Risk factors for intraabdominal septic complications after a first ileocecal resection for Crohn's disease: A multivariate analysis in 161 consecutive patients. Dis Colon Rectum 2007;50:331-336.
16. Opoien HK, Valbo A, Grinde-Andersen A, Walberg M. Postcesarian surgical site infections according to CDC standards: Rates and risk factors. A prospective cohort study. Acta Obstet Gynecol Scand 2007;86:1097-1102.
17. Gendall KA, Raniga S, Kennedy R, et al. The impact of obesity on outcome after major colorectal surgery. Dis Colon Rectum 2007;50:2223-2237.
18. Itani KMF, Jensen EH, Finn TS, et al. Effect of body mass index and ertapenem versus cefotetan prophylaxis on surgical site infection in elective colorectal surgery. Surg Infect 2008;9:131-137.
19. Lynch RJ, Ranney DN, Shijie C, et al. Obesity, surgical site infection and outcome following renal transplantation. Ann Surg 2009;250:1014-1020.
20. Giles KA,HamdanAD, Pomposelli FB, et al. Body mass index: Surgical site infections and mortality after lower extremity bypass fromtheNational SurgicalQualityImprovementProgram 2005-2007. Ann Vasc Surg 2010;24:48-56.
21. Waisbren E, Rosen H, Bader AM, et al. Percent body fat and prediction of surgical site infection. J Am Coll Surg 2010; 210:381-389.
22. Edmiston CE, Krepel C, Kelly H, et al. Perioperative antimicrobial prophylaxis in the gastric bypass patient: Do we achieve therapeutic levels? Surgery 2004;136:738-747.
23. Barbour A, Schmidt S, Rout WR, et al. Soft tissue penetration of cefuroxime determined by clinical microdialysis in morbidly obese patients undergoing abdominal surgery. Int J Antimicrob Agents 2009;34:231-235.
24. Anaya DA, Dellinger EP. The obese surgical patient: A susceptible host for infection. Surg Infect 2006;7:473-480.
25. Falagsa ME, Alexiou VG, Pappas G, et al. Do changes in antimicrobial resistance necessitate reconsideration in surgical antimicrobial prophylaxis strategies? Surg Infect 2009;10:557-562.
26. Potenza B, Diligencia M, Estigoy B, et al. Lessons learned from the institution of the surgical care improvement project at a teaching medical center. Am J Surg 2009;198:881-888.
27. Kaiser AB, Kernodle DS, Barg NL, et al. Influence of preoperative showers on staphylococcal skin colonization: A comparative trial of antiseptic skin cleansers. Ann Thorac Surg 1988;45:35-38.
28. Garibaldi RA, Skolnick D, Lerer T, et al. The impact of preoperative skin disinfection on preventing intraoperative wound contamination. Infect Control Hosp Epidemiol 1988;9:109-113.
29. Webster J, Osborne S. Preoperative bathing or showering with skin antiseptics to prevent surgical site infection [review]. Cochrane Library 2009;(4):1-34.
30. Edmiston CE, Krepel CJ, Seabrook, GR, et al. The preoperative shower revisited: Can high topical antiseptic levels be achieved on the skin surface prior to surgical admission? J Am Coll Surg 2008;207;233-239.
31. Bleasdale SC, Trick W, Gonzalez IM, et al. Effectiveness of chlorhexidine bathing to reduce catheter-associated blood stream infections in medical intensive care unit patients. Arch Intern Med 2007;167:2073-2079.
32. Popovich KJ, Hota B, Hayes R, et al. Effectiveness of routine patient cleansing with chlorhexidine gluconate for infection prevention in the medical intensive care unit. Infect Control Hosp Epidemiol 2009;30:959-963.
33. Holder C, Zellinger M. Daily bathing with chlorhexidine in the ICU to prevent central line-associated infections. J Clin Outcome Mgmt 2009;16:509-513.
34. Eiselt D. Presurgical skin preparation with a novel 2% chlorhexidine gluconate cloth reduces rates of surgical siteinfection in orthpaedic surgical patients. Orthopedic Nurs 2009;28;141-145.
35. Mangram AJ, Horan TC, Pearson ML, et al. The Hospital Infection Control Practice Advisory Committee: Guidelines for the prevention of surgical site infections. Am J Infect Control 1999;27:97-132.
36. Recommended Practices for Preoperative Patient Skin Antisepsis. In: AORN Preoperative Standards and Recommended Practices. Denver, CO. Association of periOperative Registered Nurses, 2009:550.
37. Pottinger JM, Starks SE, Steelman VM. Skin preparations. Perioperative Nurs Clin 2006;1:203-210.
38. Swenson BR, Hedrick TL, Metzger R, et al. Effect of preoperative skin preparation on postoperative wound infection rates: A prospective study of 3 skin preparation protocols Infect Control Hosp Epidemiol 2009;30:964-971.
39. Darouiche RO, Wall MJ, Itani KM, Chlorhexidine-alcohol versus povidone-iodine for surgical-site antisepsis. N Engl J Med 2010;362:18-26.
40. Paulson DS. Chlorhexidine gluconate. In Paulson DS, ed. Handbook on Topical Antimicrobials: Industrial Application in Consumer Products and Pharmaceuticals. New York. Marcel Dekker, 2003:117-122.
41. Cmich CJ, Maki DG. The promise of novel technology for prevention of intravascular device-related bloodstream infections I: Pathogenesis and short-term use devices. Clin Infect Dis 2002;34:1232-1242.
42. Lorente L, Blot S, Rello J. New issues and controversies in the prevention of ventilator-associated pneumonia. Am J Respir Crit Care Med 2010;182:870-876.
43. Cummins JS, Tomek IM, Furnes O, et al. Cost-effectiveness of antibiotic-impregnated bone cement used on primary total hip arthroplasty. J Bone J Surg 2009;91:634-641.
44. Carson CC. Efficacy of antibiotic impregnation of inflatable penile prostheses in decreasing infection in original implants. J Urol 2004;171:1514-1611.
45. Friberr O, Svedjeholm R, Soderquist B, et al. Local gentamicin reduces sternal wound infections after cardiac surgery: A randomized controlled trial. Ann Thorac Surg 2005; 79:153-161.
46. Elek SD, Cohen PE. The virulence of Staphylococcus pyogenes for man: A study of the problem of wound infection. Br J Exp Pathol 1957;38:573-586.
47. James RC, Macleod CJ. Induction of staphylococcal infections in mice with small inocula introduced on sutures. Br J Exp Pathol 1961;42:266-277.
48. Katz S, Izhar M, Mirekman D. Bacterial adherence to surgical sutures: A possible factor in suture-induced infection. Ann Surg 1981;194:35-41.
49. Rothenburger S, Spangler D, Bhende S, et al. In-vitro antimicrobial evaluation of coated Vicryl Plus® antibacterial suture (coated polyglactin 910 with triclosan) using zone of inhibition assays. Surg Infect 2002;3:S79-S87.
50. Edmiston CE, Seabrook GR, Goheen MP, et al. Bacterial adherence to surgical sutures: Can antibacterial-coated sutures reduce the risk of microbial contamination. J Am Coll Surg 2006;203:481-489.
51. Ford HR, Jones P, Gaines B. Introperative handling and wound healing: controlled clinical trial comparing coated Vicryl Plus® antibacterial suture with coated Vicryl® suture. Surg Infect 2003;3:S89-S98.
52. Fleck T, Moidl R, Blacky A, et al. Triclosan-coated sutures for the reduction of sternal wound infections: Economic consideration. Ann Thorac Surg 2007;84:232-236.
53. Rozzelle CJ, Leonard J, Veetai L. Antimicrobial suture wound closure for cerebrospinal fluid shunt surgery: A prospective, double-blinded, randomized controlled trial. J Neurosurg Pediatr 200;2:211-217.
54. Zhuang CP, Cai CY, Wang YO. Comparison of two absorbable sutures in abdominal wall incision. J Clin Rehab Tiss Eng Res 2009;13:211-215.
55. Justinger C, Moussavian MR, Schlueter C, et al. Antibiotic coating of abdominal closure sutures and wound infection. Surgery 2009;145:330-334.
56. Stone J, Gruber TJ, Rozzelle CJ. Healthcare savings associated with reduces infection rates using antimicrobial suture wound closure for cerebrospinal fluid shunt procedures. Pediatr Neurosurg 2010;46:19-24.
57. Cunningham R, Jenks SP, Northwood J, et al. Effect on MRSA transmission of rapid PCR testing of patients admitted to critical care. J Hosp Infect 2007;65:24-28.
58. Harbarth S, Frankenhauser C, Schrenzel J, et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 2008;299:1149-1157.
59. Robicsek A, Beaumont J, Paule SM, et al. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med 2008;148:409-418.
60. Byrnes MC, Adegboyega T, Riggle A, et al. Nasal swabs collected routinely to screen for colonization by methicillinresistant Staphylococcus aureus in intensive care units are a sensitive screening test for the organism in clinical cultures. Surg Infect 2010;11:511-575.
61. Kollef MH, Barie PS. Methicillin-resistant Staphylococcus aureus (MRSA) nasal colonization predicts intensive care unitacquired MRSA infections: True or false? Surg Infect 2010; 11:497-498.
62. Hentleff HJ, Barie PS, Hamilton SM, for the members of the Evidence-Based Reviews in Surgery Group. Universal nasal screening for methicillin-resistant Staphylococcus aureus in surgical patients. J Am Coll Surg 2010;211: 833-835.
63. Carson J, Lui B, Rosmus L, et al. Interpretation of MRSASelect screening agar at 24 hours of incubation. J Clin Microbiol 2009;47:566-568.
64. Elsayed S, Chow BL, Hamilton NL, et al. Development and validation of a molecular beacon probe-based real-time polymerase chain reaction assay for rapid detection of methicillin resistance in Staphylococcus aureus. Arch Pathol Lab Med 2003;127:845-849.
65. van Hal SJ, Stark D, Lockwood B, et al. Methicillin-resistant Staphylococcus aureus (MRSA) detection: Comparison of two molecular methods (IDI-MRSA PCR assay and GenoType MRSA Direct PCR assay) with three selective MRSA agars (MRSA ID, MRSASelect, and CHROMagar MRSA) for use with infection-control swabs. J Clin Microbiol 2007;45:2486-2490.
66. Pofahl WE, Goettler CE, Ramsey KM, et al. Active surveillance screening of MRSA and eradication of the carrier state decreases surgical site infections caused by MRSA. J Am Coll Surg 2009;208:981-988.
67. Bode LGM, Kluytmans J, Wertheim HF, et al. Preventing surgical site infections in nasal carriers of Staphylococcus. N Engl J Med 2010;362:9-17.
68. Kim DH, Spencer M, Davidson SM, et al. Institutional prescreening for detection and eradication of methicillin-resistant Staphylococcus aureus in patients undergoing orthopaedic surgery. J Bone Joint Surg Am 2010;92:1-7.
69. Engemann JJ, Carmeli Y, Cosgrove SE, et al. Adverse and economic outcomes attributable to methicillin-resistance among patients with Staphylococcus aureus surgical site infections. Clin Infect Dis 2003;36:592-598.
70. Edmiston CE, Seabrook GR, Cambria RA, et al. Molecular epidemiology of microbial contamination in the operating room environment: Is there a risk for infections? Surgery 2005;138:572-588.
71. Clarke MT, Lee PT, Roberts CR, et al. Contamination of primary hip replacement in standard and ultra-clean operating theaters detected by polymerase chain reaction. Acta Orthop Scand 2004;75:544-548.
72. Faibis F, Laporte C, Fiacre A, et al. An outbreak of methicillin- resistant Staphylococcus aureus surgical site infections initiated by a healthcare worker with chronic rhinosinusitis. Infect Control Hosp Epidemiol 2005;26: 213-215.
73. Solda SC, Assef JC, Parreira JG, et al. Undetected surgical glove perforation during emergency procedures. Rev Assoc Med Bras 2009;55:597-600.
74. Lancaster C, Duff P. Single versus double-gloving for obstetric and gynecologic procedures. Am J Obstet Gynecol 2007;196:e36-e37.
75. Jamal A, Wilkinson S. The mechanical and microbiological integrity of surgical gloves, Aust NZ J Surg 2003;73:140-143.
76. Kojima Y, Ohashi M. Unnoticed glove perforation at thoracoscopy and open thoracic surgery. Ann Thorac Surg 2005;80:1078-1080.
77. Misteli H, Weber WP, Reck S, et al. Surgical glove perforation and the risk of surgical site infection. Arch Surg 2009;144:553-558.
78. Daeschlein G, Kramer A, Arnold A, et al. Evaluation of an innovative antimicrobial surgical glove technology to reduce the risk of microbial passage following intraoperative perforation. Am J Infect Control 2010;39:98-103.